Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance

Biochimie

Volumn 95, Issue 3, 2013, Pages 585-594

  Murdolo, Giuseppe ^a   Piroddi, Marta ^b   Luchetti, Francesca ^c   Tortoioli, Cristina ^b   Canonico, Barbara ^c   Zerbinati, Chiara ^d   Galli, Francesco ^b   Iuliano, Luigi ^d  

^a Ospedale Assisi   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adipose tissue dysregulation; Insulin resistance; Obesity; Oxidative stress preadipocytes

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; OXYSTEROL; REACTIVE OXYGEN METABOLITE; WNT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; DIET SUPPLEMENTATION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; HUMANS; INSULIN RESISTANCE; LIPID PEROXIDATION; OBESITY; OXIDATIVE STRESS;

EID: 84874118190     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.12.014     Document Type: Review

References (134)

1. G. Frühbeck, and J. Gómez-Ambrosi Control of body weight: a physiologic and transgenic perspective Diabetologia 46 2003 143 172
2. G. Williams The regulation of energy balance: an overview G. Williams, G. Fruhbeck, Obesity: Science to Practice 2009 John Wiley & Sons, Ltd 111 124
3. A. Rodriguez, J. Gomez-Ambrosi, V. Catalan, M.J. Gil, S. Becerril, N. Sainz, C. Silva, J. Salvador, I. Colina, and G. Fruhbeck Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes Int. J. Obes. (Lond) 33 2009 541 552
4. E.A. Hamed, M.M. Zakary, N.S. Ahmed, and R.M. Gamal Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative stress Diabetes Res. Clin. Pract. 94 2011 434 441
5. G. Fruhbeck Obesity: aquaporin enters the picture Nature 438 2005 436 437
6. G. Fruhbeck, V. Catalan, J. Gomez-Ambrosi, and A. Rodriguez Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways Trends Pharmacol. Sci. 27 2006 345 347
7. G. Murdolo, P. Lucidi, C. Di Loreto, N. Parlanti, A. De Cicco, C. Fatone, C.G. Fanelli, G.B. Bolli, F. Santeusanio, and P. De Feo Insulin is required for prandial ghrelin suppression in humans Diabetes 52 2003 2923 2927
8. J.P. Despres, and I. Lemieux Abdominal obesity and metabolic syndrome Nature 444 2006 881 887
9. G.H. Goossens The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance Physiol. Behav. 94 2008 206 218
10. C.X. Andersson, B. Gustafson, A. Hammarstedt, S. Hedjazifar, and U. Smith Inflamed adipose tissue, insulin resistance and vascular injury Diabetes Metab. Res. Rev. 24 2008 595 603
11. G. Fruhbeck Overview of adipose tissue and its role in obesity and metabolic disorders K. Yang, Adipose Tissue Protocols. Methods in Molecular Biology 2006 Humana Press 1 22
12. N. Ruderman, D. Chisholm, X. Pi-Sunyer, and S. Schneider The metabolically obese, normal weight individual revisited Diabetes 47 1998 699 713
13. M. Bluher The distinction of metabolically 'healthy' from 'unhealthy' obese individuals Curr. Opin. Lipidol. 21 2010 38 43
14. N. Klöting, M. Fasshauer, A. Dietrich, P. Kovacs, M. Schön, M. Kern, M. Stumvoll, and M. Blüher Insulin-sensitive obesity Am. J. Physiol. Endocrinol. Metab. 299 2010 E506 E515
15. J. Gomez-Ambrosi, C. Silva, J.C. Galofre, J. Escalada, S. Santos, D. Millan, N. Vila, P. Ibanez, M.J. Gil, V. Valenti, F. Rotellar, B. Ramirez, J. Salvador, and G. Fruhbeck Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity Int. J. Obes. (Lond) 36 2012 286 294
16. K. Sun, M. Christine, M. Kusminski, and P. Scherer Adipose tissue remodelling in obesity J. Clin. Invest. 121 2011 2094 2101
17. S. Cinti The adipose organ at a glance Dis. Model. Mech. 5 2012 588 594
18. S. Virtue, and A. Vidal-Puig Adipose tissue expandability, lipotoxicity and the metabolic syndrome. An allostatic perspective Biochim. Biophys. Acta 1801 2010 338 349
19. E. Danforth Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat. Genet. 26 2000 13
20. C. Christodoulides, C. Lagathu, J.K. Sethi, and A. Vidal-Puig Adipogenesis and WNT signalling Trends Endocrinol. Metab. 20 2009 16 24
21. J.K. Sethi Activatin human adipose progenitors in obesity Diabetes 59 2010 2354 2357
22. G. Lin, M. Garcia, H. Ning, L. Banie, Y. Guo, T. Lue, and C. Lin Defining stem and progenitor cells within adipose tissue Stem Cell. Dev. 17 2008 1053 1063
23. M. Krotkiewski, P. Bjorntorp, L. Sjostrom, and U. Smith Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution J. Clin. Invest. 72 1983 1150 1162
24. K.L. Spalding, E. Arner, P.O. Westermark, S. Bernard, B.A. Buchholz, O. Bergmann, L. Blomqvist, J. Hoffstedt, E. Naslund, T. Britton, H. Concha, M. Hassan, M. Ryden, J. Frisen, and P. Arner Dynamics of fat cell turnover in humans Nature 453 2008 783 787
25. P. Isakson, A. Hammarstedt, B. Gustafson, and U. Smith Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation Diabetes 58 2009 1550 1557
26. E. Arner, P.O. Westermark, K.L. Spalding, T. Britton, M. Ryden, J. Frisen, S. Bernard, and P. Arner Adipocyte turnover: relevance to human adipose tissue morphology Diabetes 59 2010 105 109
27. B. Gustafson, and U. Smith The Wnt inhibitor Dicckopf 1 and Bone Morphogenetic Protein 4 rescue adipogenesis in hypertrophic obesity in human Diabetes 61 2012 1217 1224
28. N. Stefan, S. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Ritting, B. Balletshofer, F. Machicao, A. Fritsche, and H. Haring Identification and characterization of metabolically benign obesity in humans Arch. Intern. Med. 168 2008 1609 1616
29. M. Lundgren, M. Svensson, S. Lindmark, M. Rendtrom, T. Ruge, and J.W. Eriksson Fat cell enlargement is an independent marker of insulin resistance and "hyperleptinemia" Diabetologia 50 2007 625 633
30. C. Weyer, J. Foley, C. Bogardus, B. Howard, and E. Ravussin Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance Diabetologia 43 2000 1498 1506
31. P.A. Jansson, F. Pellme, A. Hammarstedt, M. Sandqvist, H. Brekke, K. Caidahl, M. Forsberg, R. Volkmann, E. Carvalho, T. Funahashi, Y. Matsuzawa, O. Wiklund, X. Yang, M.R. Taskinen, and U. Smith A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin Faseb J. 17 2003 1434 1440
32. S.G. Dubois, L.K. Heilbronn, S.R. Smith, J.B. Albu, D.E. Kelley, and E. Ravussin Decreased expression of adipogenic genes in obese subjects with type 2 diabetes Obesity (Silver Spring) 14 2006 1543 1552
33. F.H. van Tienen, C.J. van der Kallen, P.J. Lindsey, R.J. Wanders, M.M. van Greevenbroek, and H.J. Smeets Preadipocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity Int. J. Obes. (Lond) 35 2011 1154 1164
34. M.Y. Wang, P. Grayburn, S. Chen, M. Ravazzola, L. Orci, and R.H. Unger Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome Proc. Natl. Acad. Sci. USA 105 2008 6139 6144
35. P. Arner, E. Arner, A. Hammarstedt, and U. Smith Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis PLoS One 6 2011 e18284
36. H.T. Park, E.S. Lee, Y.P. Cheon, D.R. Lee, K.S. Yang, Y.T. Kim, J.Y. Hur, S.H. Kim, K.W. Lee, and T. Kim The relationship between fat depot-specific preadipocyte differentiation and metabolic syndrome in obese women Clin. Endocrinol. (Oxf) 76 2012 59 66
37. U. Smith Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance-is insulin resistance initiated in the adipose tissue? Int. J. Obes. Relat. Metab. Disord. 26 2002 897 904
38. B. Gustafson, A. Hammarstedt, C.X. Andersson, and U. Smith Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis Arterioscler. Thromb. Vasc. Biol. 27 2007 2276 2283
39. G. Murdolo, and U. Smith The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis Nutr. Metab. Cardiovasc. Dis. 16 Suppl. 1 2006 S35 S38
40. B. Gustafson, S. Gogg, S. Hedjazifar, L. Jenndahl, A. Hammarstedt, and U. Smith Inflammation and impaired adipogenesis in hypertrophic obesity in man Am. J. Physiol. Endocrinol. Metab. 297 2009 E999 E1003
41. U. Smith, and A. Hammarstedt Antagonistic effects of thiazolidinediones and cytokines in lipotoxicity Biochim. Biophys. Acta 2009
42. H. Cao, K. Gerhold, J.R. Mayers, M.M. Wiest, S.M. Watkins, and G.S. Hotamisligil Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism Cell 134 2008 933 944
43. D. Mozaffarian, H. Cao, I.B. King, R.N. Lemaitre, X. Song, D.S. Siscovick, and G.S. Hotamisligil Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes Am. J. Clin. Nutr. 92 2010 1350 1358
44. N. Stefan, K. Kantartzis, N. Celebi, H. Staiger, J. Machann, F. Schick, A. Cegan, M. Elcnerova, E. Schleicher, A. Fritsche, and H.U. Haring Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans Diabetes Care 33 2010 405 407
45. D. Iggman, J. Arnlov, B. Vessby, T. Cederlhom, P. Sjogren, and U. Riserus Adipose tissue fatty acids and insulin sensitivity in elderly men Diabetologia 53 2010 850 857
46. R. Roberts, L. Hodson, A. Dennis, M. Neville, S. Humphreys, K. Harndern, K. Mickelm, and K. Frayn Markers of the novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans Diabetologia 52 2009 882 890
47. V. Catalan, J. Gomez-Ambrosi, A. Rodriguez, C. Silva, F. Rotellar, M.J. Gil, J.A. Cienfuegos, J. Salvador, and G. Fruhbeck Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation Clin. Endocrinol. (Oxf) 68 2008 213 219
48. J.M. Fernandez-Real, V. Catalan, J.M. Moreno-Navarrete, J. Gomez-Ambrosi, F.J. Ortega, J.I. Rodriguez-Hermosa, W. Ricart, and G. Fruhbeck Study of caveolin-1 gene expression in whole adipose tissue and its subfractions and during differentiation of human adipocytes Nutr. Metab. (Lond) 7 2010 20
49. G. Fruhbeck, M. Lopez, and C. Dieguez Role of caveolins in body weight and insulin resistance regulation Trends Endocrinol. Metab. 18 2007 177 182
50. B. Gustafson, and U. Smith Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes J. Biol. Chem. 281 2006 9507 9516
51. V. Catalan, J. Gomez-Ambrosi, A. Rodriguez, B. Ramirez, C. Silva, F. Rotellar, M.J. Gil, J.A. Cienfuegos, J. Salvador, and G. Fruhbeck Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans J. Mol. Med. (Berl) 87 2009 803 813
52. G. Zhuang, C. Meng, X. Guo, P.S. Cheruku, L. Shi, H. Xu, H. Li, G. Wang, A.R. Evans, S. Safe, C. Wu, and B. Zhou A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation Circulation 125 2012 2892 2903
53. A. Hammarstedt, P. Isakson, B. Gustafson, and U. Smith Wnt-signaling is maintained and adipogenesis inhibited by TNFalpha but not MCP-1 and resistin Biochem. Biophys. Res. Commun. 357 2007 700 706
54. V. Puri, S. Ranjit, S. Konda, S.M. Nicoloro, J. Straubhaar, A. Chawla, M. Chouinard, C. Lin, A. Burkart, S. Corvera, R.A. Perugini, and M.P. Czech Cidea is associated with lipid droplets and insulin sensitivity in humans Proc. Natl. Acad. Sci. USA 105 2008 7833 7838
55. E. Rosen, and O. MacDougald Adipocyte differentiation from the inside out Nature 7 2006 885 896
56. B. Feve Adipogenesis: cellular and molecular aspects Best Pract. Res. Clin. Endocrinol. Metab. 19 2005 483 499
57. T.C. Prestwich, and O.A. Macdougald Wnt/beta-catenin signaling in adipogenesis and metabolism Curr. Opin. Cell. Biol. 19 2007 612 617
58. R.R. Bowers, and M.D. Lane Wnt signaling and adipocyte lineage commitment Cell Cycle 7 2008 1191 1196
59. V. Krishnan, H.U. Bryant, and O.A. Macdougald Regulation of bone mass by Wnt signaling J. Clin. Invest. 116 2006 1202 1209
60. J.K. Sethi, and A. Vidal-Puig Wnt signalling and the control of cellular metabolism Biochem. J. 427 2010 1 17
61. B. Gustafson, and U. Smith Activation of canonical Wingless-type MMTV integration site family (WNT) signaling in mature adipocytes increases β-catenin levels and leads to cell dedifferentiation and insulin resistance J. Biol. Chem. 285 2010 14031 14041
62. B. Gustafson, and U. Smith WNT signalling is both an inducer and effector of glucagon-like peptide-1 Diabetologia 51 2008 1768 1770
63. C. Lagathu, C. Christodoulides, S. Virtue, W.P. Cawthorn, C. Franzin, W.A. Kimber, E.D. Nora, M. Campbell, G. Medina-Gomez, B.N. Cheyette, A.J. Vidal-Puig, and J.K. Sethi Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network Diabetes 58 2009 609 619
64. A. Kikuchi, H. Yamamoto, and A. Sato Selective activation mechanisms of Wnt signaling pathways Trends Cell. Biol. 19 2009 119 129
65. K. Willert, J.D. Brown, E. Danenberg, A.W. Duncan, I.L. Weissman, T. Reya, J.R. Yates 3rd, and R. Nusse Wnt proteins are lipid-modified and can act as stem cell growth factors Nature 423 2003 448 452
66. C.Y. Logan, and R. Nusse The Wnt signaling pathway in development and disease Annu. Rev. Cell. Dev. Biol. 20 2004 781 810
67. S.E. Ross, N. Hemati, K.A. Longo, C.N. Bennett, P.C. Lucas, R.L. Erickson, and O.A. MacDougald Inhibition of adipogenesis by Wnt signaling Science 289 2000 950 953
68. X. Yang, P.A. Jansson, I. Nagaev, M.M. Jack, E. Carvalho, K.S. Sunnerhagen, M.C. Cam, S.W. Cushman, and U. Smith Evidence of impaired adipogenesis in insulin resistance Biochem. Biophys. Res. Commun. 317 2004 1045 1051
69. S.F. Grant, G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sainz, A. Helgason, H. Stefansson, V. Emilsson, A. Helgadottir, U. Styrkarsdottir, K.P. Magnusson, G.B. Walters, E. Palsdottir, T. Jonsdottir, T. Gudmundsdottir, A. Gylfason, J. Saemundsdottir, R.L. Wilensky, M.P. Reilly, D.J. Rader, Y. Bagger, C. Christiansen, V. Gudnason, G. Sigurdsson, U. Thorsteinsdottir, J.R. Gulcher, A. Kong, and K. Stefansson Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat. Genet. 38 2006 320 323
70. E.K. Speliotes, C.J. Willer, S.I. Berndt, K.L. Monda, and G. Thorleifsson Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index Nat. Genet. 42 2010 937 948
71. B. Gustafson, B. Eliasson, and U. Smith Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis Diabetologia 53 2010 536 540
72. J.R. Park, J.W. Jung, Y.S. Lee, and K.S. Kang The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells Cell. Prolif. 41 2008 859 874
73. L. Iuliano Pathways of cholesterol oxidation via non-enzymatic mechanisms Chem. Phys. Lipids 164 2011 457 468
74. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
75. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura Increased oxidative stress in obesity and its impact on metabolic syndrome J. Clin. Invest. 114 2004 1752 1761
76. N. Houstis, E.D. Rosen, and E.S. Lander Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 440 2006 944 948
77. H. Lee, Y.J. Lee, H. Choi, E.H. Ko, and J.W. Kim Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion J. Biol. Chem. 284 2009 10601 10609
78. H.M. Findeisen, F. Gizard, Y. Zhao, H. Qing, K.L. Jones, D. Cohn, E.B. Heywood, and D. Bruemmer Glutathione depletion prevents diet-induced obesity and enhances insulin sensitivity Obesity (Silver Spring) 19 2011 2429 2432
79. N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species Physiol. Rev. 89 2009 27 71
80. Y.M. Janssen-Heininger, B.T. Mossman, N.H. Heintz, H.J. Forman, B. Kalyanaraman, T. Finkel, J.S. Stamler, S.G. Rhee, and A. van der Vliet Redox-based regulation of signal transduction: principles, pitfalls, and promises Free Radic. Biol. Med. 45 2008 1 17
81. H.M. Findeisen, K.J. Pearson, F. Gizard, Y. Zhao, H. Qing, K.L. Jones, D. Cohn, E.B. Heywood, R. de Cabo, and D. Bruemmer Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis PLoS One 6 2011 e18532
82. C. Gummersbach, K. Hemmrich, K.D. Kroncke, C.V. Suschek, K. Fehsel, and N. Pallua New aspects of adipogenesis: radicals and oxidative stress Differentiation 77 2009 115 120
83. Y. Funato, and H. Miki Redox regulation of Wnt signalling via nucleoredoxin Free Radic. Res. 44 2010 379 388
84. A. Galinier, A. Carriere, Y. Fernandez, C. Carpene, M. Andre, S. Caspar-Bauguil, J.P. Thouvenot, B. Periquet, L. Penicaud, and L. Casteilla Adipose tissue proadipogenic redox changes in obesity J. Biol. Chem. 281 2006 12682 12687
85. K. Schroder, K. Wandzioch, I. Helmcke, and R.P. Brandes Nox4 acts as a switch between differentiation and proliferation in preadipocytes Arterioscler. Thromb. Vasc. Biol. 29 2009 239 245
86. S.C. Manolagas, and M. Almeida Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism Mol. Endocrinol. 21 2007 2605 2614
87. S. Mouche, S.B. Mkaddem, W. Wang, M. Katic, Y.H. Tseng, S. Carnesecchi, K. Steger, M. Foti, C.A. Meier, P. Muzzin, C.R. Kahn, E. Ogier-Denis, and I. Szanto Reduced expression of the NADPH oxidase NOX4 is a hallmark of adipocyte differentiation Biochim. Biophys. Acta 1773 2007 1015 1027
88. M. Curzio, C. Di Mauro, H. Esterbauer, and M.U. Dianzani Chemotactic activity of aldehydes. Structural requirements. Role in inflammatory process Biomed. Pharmacother. 41 1987 304 314
89. Y. Zhang, and X. Chen Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation Am. J. Physiol. Endocrinol. Metab. 300 2011 E77 E85
90. F. Bost, M. Aouadi, L. Caron, and B. Binetruy The role of MAPKs in adipocyte differentiation and obesity Biochimie 87 2005 51 56
91. W.K. Kim, V. Meliton, C.M. Amantea, T.J. Hahn, and F. Parhami 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism J. Bone Miner. Res. 22 2007 1711 1719
92. H.T. Kha, B. Basseri, D. Shouhed, J. Richardson, S. Tetradis, T.J. Hahn, and F. Parhami Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat J. Bone Miner. Res. 19 2004 830 840
93. C.M. Amantea, W.K. Kim, V. Meliton, S. Tetradis, and F. Parhami Oxysterol-induced osteogenic differentiation of marrow stromal cells is regulated by Dkk-1 inhibitable and PI3-kinase mediated signaling J. Cell. Biochem. 105 2008 424 436
94. T. Zhou, K.K. Zhou, K. Lee, G. Gao, T.J. Lyons, R. Kowluru, and J.X. Ma The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy Diabetologia 54 2011 459 468
95. L. Iuliano, D. Praticò, A. Ghiselli, M.S. Bonavita, and F. Violi Reaction of dipyridamole with the hydroxyl radical Lipids 27 1992 349 353
96. M.P. Mattson Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders Exp. Gerontol. 44 2009 625 633
97. G. Poli, R.J. Schaur, W.G. Siems, and G. Leonarduzzi 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest Med. Res. Rev. 28 2008 569 631
98. Y. Riahi, G. Cohen, O. Shamni, and S. Sasson Signaling and cytotoxic functions of 4-hydroxyalkenals Am. J. Physiol. Endocrinol. Metab. 299 2010 E879 E886
99. N.J. Pillon, L. Soulere, R.E. Vella, M. Croze, B.R. Care, H.A. Soula, A. Doutheau, M. Lagarde, and C.O. Soulage Quantitative structure-activity relationship for 4-hydroxy-2-alkenal induced cytotoxicity in L6 muscle cells Chem. Biol. Interact. 188 2010 171 180
100. A. Otaegui-Arrazola, M. Menendez-Carreno, D. Ansorena, and I. Astiasaran Oxysterols: a world to explore Food Chem. Toxicol. 48 2010 3289 3303
101. D. Demozay, J.C. Mas, S. Rocchi, and E. Van Obberghen FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes Diabetes 57 2008 1216 1226
102. N.J. Pillon, M.L. Croze, R.E. Vella, L. Soulere, M. Lagarde, and C.O. Soulage The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress Endocrinology 153 2012
103. N.J. Pillon, R.E. Vella, L. Souleere, M. Becchi, M. Lagarde, and C.O. Soulage Structural and functional changes in human insulin induced by the lipid peroxidation byproducts 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal Chem. Res. Toxicol. 24 2011 752 762
104. K. Endo, T. Oyama, A. Saiki, N. Ban, M. Ohira, N. Koide, T. Murano, H. Watanabe, M. Nishii, M. Miura, K. Sekine, Y. Miyashita, and K. Shirai Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus Diabetes Res. Clin. Pract. 80 2008 63 68
105. M. Wamil, R. Andrew, K.E. Chapman, J. Street, N.M. Morton, and J.R. Seckl 7-Oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type Endocrinology 149 2008 5909 5918
106. S.P. Singh, M. Niemczyk, D. Saini, Y.C. Awasthi, L. Zimniak, and P. Zimniak Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice Biochemistry 47 2008 3900 3911
107. S. Toyokuni, S. Yamada, M. Kashima, Y. Ihara, Y. Yamada, T. Tanaka, H. Hiai, Y. Seino, and K. Uchida Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus Antioxid. Redox Signal. 2 2000 681 685
108. B.A. Janowski, P.J. Willy, T.R. Devi, J.R. Falck, and D.J. Mangelsdorf An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha Nature 383 1996 728 731
109. C. Murphy, A.M. Murray, S. Meaney, and M. Gafvels Regulation by SREBP-2 defines a potential link between isoprenoid and adenosylcobalamin metabolism Biochem. Biophys. Res. Commun. 355 2007 359 364
110. V.M. Olkkonen, and R. Hynynen Interactions of oxysterols with membranes and proteins Mol. Aspects Med. 30 2009 123 133
111. R.K. Mann, and P.A. Beachy Novel lipid modifications of secreted protein signals Annu. Rev. Biochem. 73 2004 891 923
112. H. Waki, K.W. Park, N. Mitro, L. Pei, R. Damoiseaux, D.C. Wilpitz, K. Reue, E. Saez, and P. Tontonoz The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression Cell. Metab. 5 2007 357 370
113. B.R. Krause, and A.D. Hartman Adipose tissue and cholesterol metabolism J. Lipid Res. 25 1984 97 110
114. S. Le Lay, S. Krief, C. Farnier, I. Lefrere, X. Le Liepvre, R. Bazin, P. Ferre, and I. Dugail Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes J. Biol. Chem. 276 2001 16904 16910
115. P.C. Chui, H.P. Guan, M. Lehrke, and M.A. Lazar PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 J. Clin. Invest. 115 2005 2244 2256
116. A.J. Brown, S.L. Leong, R.T. Dean, and W. Jessup 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque J. Lipid Res. 38 1997 1730 1745
117. S. Ferderbar, E.C. Pereira, E. Apolinario, M.C. Bertolami, A. Faludi, O. Monte, L.E. Calliari, J.E. Sales, A.R. Gagliardi, H.T. Xavier, and D.S. Abdalla Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus Diabetes Metab. Res. Rev. 23 2007 35 42
118. R. Masella, R. Vari, M. D'Archivio, C. Santangelo, B. Scazzocchio, M.T. Maggiorella, L. Sernicola, F. Titti, M. Sanchez, U. Di Mario, G. Leto, and C. Giovannini Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation FEBS Lett. 580 2006 2421 2429
119. B. Scazzocchio, R. Vari, M. D'Archivio, C. Santangelo, C. Filesi, C. Giovannini, and R. Masella Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases J. Lipid Res. 50 2009 832 845
120. J.R. Dwyer, N. Sever, M. Carlson, S.F. Nelson, P.A. Beachy, and F. Parhami Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells J. Biol. Chem. 282 2007 8959 8968
121. K.H. Ingram, H. Hill, D.R. Moellering, B.G. Hill, C. Lara-Castro, B. Newcomer, L.J. Brandon, C.P. Ingalls, M. Penumetcha, J.C. Rupp, and W.T. Garvey Skeletal muscle lipid peroxidation and insulin resistance in humans J. Clin. Endocrinol. Metab. 97 2012
122. M. Mogensen, K. Sahlin, M. Fernstrom, D. Glintborg, B.F. Vind, H. Beck-Nielsen, and K. Hojlund Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes Diabetes 56 2007 1592 1599
123. I. Miwa, N. Ichimura, M. Sugiura, and Y.T.S. Hamada Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products Endocrinology 141 2000 2767 2772
124. U. Smith, M. Axelsen, E. Carvalho, B. Eliasson, P.A. Jansson, and C. Wesslau Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes Ann. N.Y. Acad. Sci. 892 1999 119 126
125. B.G. Hill, P. Haberzettl, Y. Ahmed, S. Srivastava, and A. Bhatnagar Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells Biochem. J. 410 2008 525 534
126. P.A. Grimsrud, M.J. Picklo Sr., T.J. Griffin, and D.A. Bernlohr Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal Mol. Cell. Proteomics 6 2007 624 637
127. D. Demozay, S. Rocchi, J.C. Mas, S. Grillo, L. Pirola, C. Chavey, and E. Van Obberghen Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin J. Biol. Chem. 279 2004 6261 6270
128. S. Descamps, H. Arzouk, F. Bacou, H. Bernardi, Y. Fedon, S. Gay, Y. Reyne, B. Rossano, and J. Levin Inhibition of myoblast differentiation by Sfrp1 and Sfrp2 Cell. Tissue Res. 332 2008 299 306
129. A.F. Soares, M. Guichardant, D. Cozzone, N. Bernoud-Hubac, N. Bouzaidi-Tiali, M. Lagarde, and A. Geloen Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes Free Radic. Biol. Med. 38 2005 882 889
130. B. Zarrouki, A.F. Soares, M. Guichardant, M. Lagarde, and A. Geloen The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell FEBS Lett. 581 2007 2394 2400
131. J.L. Evans Antioxidants: do they have a role in the treatment of insulin resistance? Indian J. Med. Res. 125 2007 355 372
132. K. Hemmrich, C. Gummersbach, N. Pallua, C. Luckhaus, and K. Fehsel Clozapine enhances differentiation of adipocyte progenitor cells Mol. Psychiatry 11 2006 980 981
133. A. Dalla Libera, G. Scutari, R. Boscolo, M.P. Rigobello, and A. Bindoli Antioxidant properties of clozapine and related neuroleptics Free Radic. Res. 29 1998 151 157
134. S. Akbar, S. Bellary, and H.R. Griffiths Dietary antioxidant interventions in type 2 diabetes patients Br J Diab Vasc Dis. 11 2011 62 68